TRIGEN ADVANCING CARDIOVASCULAR CARE Trademark

Trademark Overview


On Monday, May 15, 2006, a trademark application was filed for TRIGEN ADVANCING CARDIOVASCULAR CARE with the United States Patent and Trademark Office. The USPTO has given the TRIGEN ADVANCING CARDIOVASCULAR CARE trademark a serial number of 78883882. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, December 8, 2009. This trademark is owned by Trigen Limited. The TRIGEN ADVANCING CARDIOVASCULAR CARE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research for medical purposes; drug discovery and drug development services, consultancy services relating to the discovery, development and evaluation of drugs, technical support services, all provided by a pharmaceutical research and/or development company; research and development services to find and develop new pharmaceutical products for others to put on the market; pharmaceutical research services; pharmaceutical research services enabling others to acquire licences or other rights relating to the results or benefits, including candidate pharmaceutical products, arising from the research; arranging investigations and/or research to obtain information and/or data, to be supplied to others, relating to drugs, formulations and/or candidate pharmaceutical products; preparing or arranging the preparation of chemicals, biological products, formulations and/or candidate pharmaceutical products to enable others to acquire information, data and/or rights relating to the prepar...
trigen advancing cardiovascular care

General Information


Serial Number78883882
Word MarkTRIGEN ADVANCING CARDIOVASCULAR CARE
Filing DateMonday, May 15, 2006
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, December 8, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedThe color(s) red (Pantone 187), yellow (Pantone 116) and a linear gradient blend thereof is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "TRIGEN" next to a stylized oval, all above the words "ADVANCING CARDIOVASCULAR CARE".
Goods and ServicesScientific research for medical purposes; drug discovery and drug development services, consultancy services relating to the discovery, development and evaluation of drugs, technical support services, all provided by a pharmaceutical research and/or development company; research and development services to find and develop new pharmaceutical products for others to put on the market; pharmaceutical research services; pharmaceutical research services enabling others to acquire licences or other rights relating to the results or benefits, including candidate pharmaceutical products, arising from the research; arranging investigations and/or research to obtain information and/or data, to be supplied to others, relating to drugs, formulations and/or candidate pharmaceutical products; preparing or arranging the preparation of chemicals, biological products, formulations and/or candidate pharmaceutical products to enable others to acquire information, data and/or rights relating to the preparative techniques and/or prepared products; the provision of reports and information relating to chemicals, biological products, the preparation of either, formulations, candidate pharmaceutical products, pharmaceutical or medical research projects, pharmaceutical or medical research services, medicine, chemistry, molecular biology, disease and/property rights; the obtainment and compilation, for the benefit of others, of information, data and/or documents relating to candidate pharmaceutical products, enabling prospective business partners, licensees and/or assignees to assess the information, data and/or documents; acquiring or arranging the acquisition of intellectual property rights (including the preparation, filing and prosecution of patent applications), to enable others to licence-in or buy-in the rights; licensing of intellectual property rights; assigning intellectual property rights; provision on the Internet of documents and information relating to chemicals, biological molecules, the preparation of either, pharmaceutical agents, pharmaceutical formulations, candidate pharmaceutical products, pharmaceutical or medical research project, pharmaceutical or medical research services, chemistry, molecular biology, disease and/or intellectual property rights; scientific and pharmaceutical research services relating to blood clotting and/or thrombosis and to substances for use in controlling blood clotting or for the treatment or prevention of thrombosis; provision of information relating to research and development activities concerning blood clotting, thrombosis, and/or substances for use in controlling blood clotting or for the treatment or prevention of thrombosis

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 19, 2006
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTrigen Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon SW1A 1ES
GB

Trademark Events


Event DateEvent Description
Tuesday, December 8, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, December 8, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 12, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2009NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2009NON-FINAL ACTION WRITTEN
Tuesday, April 21, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, April 21, 2009ASSIGNED TO LIE
Friday, October 17, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 17, 2008ASSIGNED TO LIE
Thursday, April 17, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 17, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 6, 2007LETTER OF SUSPENSION E-MAILED
Friday, April 6, 2007SUSPENSION LETTER WRITTEN
Friday, March 30, 2007AMENDMENT FROM APPLICANT ENTERED
Friday, February 23, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 30, 2007ASSIGNED TO LIE
Friday, February 23, 2007PAPER RECEIVED
Thursday, August 24, 2006NON-FINAL ACTION E-MAILED
Thursday, August 24, 2006NON-FINAL ACTION WRITTEN
Thursday, August 24, 2006ASSIGNED TO EXAMINER
Saturday, May 20, 2006NOTICE OF DESIGN SEARCH CODE MAILED
Friday, May 19, 2006NEW APPLICATION ENTERED IN TRAM